TQB3915
/ Sino Biopharm
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
June 13, 2022
Phase I Clinical Trial of TQB3915 Tablets in Subjects With Advanced Malignant Solid Tumors
(clinicaltrials.gov)
- P1 | N=70 | Recruiting | Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
New P1 trial • Oncology • Solid Tumor
1 to 1
Of
1
Go to page
1